The safety of using anti-VEGF: Is there strength in numbers? Curtis LH, Hammill BG, Schulman KA, Cousins SW (2010) Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Arch Ophthalmol 128(10):1273

The safety of using anti-VEGF: Is there strength in numbers? Curtis LH, Hammill BG, Schulman KA, Cousins SW (2010) Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Arch Ophthalmol 128(10):1273–1279

Published:2011-01-06 Issue:2 Volume:249 Page:161-162
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefes Arch Clin Exp Ophthalmol

Author:

Wong David,Joussen Antonia M.

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

http://www.springerlink.com/index/pdf/10.1007/s00417-010-1603-7

Reference3 articles.

1. NICE Technology Appraisal 155, Issued August 2008. Pegaptanib and ranibizumab for the treatment of age-related macular degeneration.

2. http://news.xinhuanet.com/english2010/china/2010-09/15/c_13495920.htm accessed on 9 December 2010

3. Curtis LH, Hammill BG, Schulman KA, Cousins SW (2010) Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Arch Ophthalmol 128(10):1273–1279

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Studies of Real Estate Agency Practices and the Way Forward;Environment-Behaviour Proceedings Journal;2024-02-24

2. Gene Delivery of Calreticulin Anti-Angiogenic Domain Attenuates the Development of Choroidal Neovascularization in Rats;Human Gene Therapy;2017-05

3. Age-Related Macular Degeneration and Mortality: A Systematic Review and Meta-Analysis;Ophthalmic Epidemiology;2017-01-31

4. Incidence of Myocardial Infarction, Stroke, and Death in Patients With Age-Related Macular Degeneration Treated With Intravitreal Anti–Vascular Endothelial Growth Factor Therapy;American Journal of Ophthalmology;2015-03

5. Systemic Vascular Safety of Ranibizumab for Age-Related Macular Degeneration;Ophthalmology;2014-11